Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined biologic therapy and chemotherapy for inoperable cholangiocarcinoma
2008-002367-14Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Jun 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panitumumab in cholangiocarcinoma (CCA) and gallbladder adenocarcinoma, sponsored by Vejle Hospital. Primary endpoint: progression-free survival. Started Jun 2008; status: completed.
02
Drugs
panitumumab
03
Conditions
cholangiocarcinoma (CCA)gallbladder adenocarcinoma
Beyond the preview
Go deeper on 2008-002367-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002367-14.